Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioventix specializes in creating high-affinity sheep monoclonal antibodies for clinical diagnostics. The company's SMAs are used in blood-testing diagnostics for heart disease, cancer, infertility, and other serious conditions. Bioventix has developed over 20 SMAs that have become preferred reagents in in-vitro diagnostic assays due to increased affinity, greater specificity, or improved affinity and specificity compared to conventional antibodies. The company also offers ELISA kits for detecting industrial pollutants and is collaborating on Alzheimer's research with a leading global laboratory.[1][2][3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioventix.